Article

Treatment with Arbidol and Moxifloxacin in Ordinary and Severe Adult Patients Infected with COVID-19

2020-06-05

Abstract excerpt

<h4>Background</h4> An outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been widely spread. We aim to investigate the therapeutic effect of arbidol and moxifloxacin in patients infected with SARS-CoV-2. <h4>Methods</h4> We collected and analyzed data on 94 patients with COVID-19 including 27 severe patients at the Intensive Care Unit (ICU) a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f9f5b079-e549-5d94-891f-8fe20bd003f3
DOI: 10.1101/2020.05.30.20117598

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Treatment with Arbidol and Moxifloxacin in Ordinary and Severe Adult Patients Infected with COVID-19DOI 10.1101/2020.05.30.20117598Read

Efficacy and Safety Evaluation of Arbidol in Patients with COVID-19Semantic proximity Read

Multi-center, randomized controlled, open evaluation of efficacy and safety of Arbidol hydrochloride tablets in the treatment of influenza-like casesSemantic proximity Read

Current status and clinical outcomes of pharmacotherapies according to SARS-CoV-2 mutations in patients with mild-to-moderate COVID-19: a retrospective single center study.Semantic proximity Read

Efficacy and Safety of AYUSH-64 in COVID-19: A Systematic Review and Meta-AnalysisSemantic proximity Read

Effectiveness of Molnupiravir for the Treatment of COVID-19: A Systematic Literature Review of Real-World Observational StudiesSemantic proximity Read

Effectiveness of Molnupiravir for the Treatment of COVID-19: A Systematic Literature Review of Real-World Observational StudiesSemantic proximity Read

Hydroxychloroquine with or Without Azithromycin for Treatment of Early SARS-CoV-2 Infection Among High-Risk Outpatient Adults: A Randomized Clinical TrialSemantic proximity Read

Outpatient regimens to reduce COVID-19 hospitalisations: a systematic review and meta-analysis of randomized controlled trialsSemantic proximity Read

REGEN-COV antibody cocktail (casirivimab/imdevimab) for the treatment of inpatients with early hospital-acquired COVID-19: a single center experienceSemantic proximity Read

From SARS and MERS to COVID-19: a review of the quality and responsiveness of clinical management guidelines in outbreak settingsSemantic proximity Read

<strong>Pathogenesis, Diagnosis and Possible Therapeutic Options for COVID-19</strong>Semantic proximity Read

Ensitrelvir Fumaric Acid in Patients with SARS-CoV-2: A Retrospective Chart ReviewSemantic proximity Read